Search Results

You are looking at 1 - 10 of 26 items for :

  • endocrine factors x
  • Hormones and Cancer x
Clear All
E K White Division of Endocrinology and Centre for Endocrine Tumors, Department of Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by E K White in
Google Scholar
PubMed
Close
,
I V Wagner Department of Endocrinology & Metabolism, Amsterdam University Medical Centre, Amsterdam, The Netherlands

Search for other papers by I V Wagner in
Google Scholar
PubMed
Close
,
C van Beuzekom Division of Endocrinology and Centre for Endocrine Tumors, Department of Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by C van Beuzekom in
Google Scholar
PubMed
Close
,
V Iotova Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck, Lübeck, Germany

Search for other papers by V Iotova in
Google Scholar
PubMed
Close
,
S F Ahmed Office for Rare Conditions, University of Glasgow, Glasgow, UK
Department of Paediatrics, UMHAT ‘Sveta Marina’ Varna, Medical University of Varna, Varna, Bulgaria

Search for other papers by S F Ahmed in
Google Scholar
PubMed
Close
,
O Hiort Department of Endocrinology & Metabolism, Amsterdam University Medical Centre, Amsterdam, The Netherlands

Search for other papers by O Hiort in
Google Scholar
PubMed
Close
, and
A M Pereira Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by A M Pereira in
Google Scholar
PubMed
Close

patients with rare endocrine conditions. In our system usage statistics ( Fig. 2 ), we can see that the number of active users and panels has declined in 2021. Apart from the time factor which might be a strong hurdle to use the CPMS, the COVID-19

Open access
Hélène Singeisen Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Close
,
Mariko Melanie Renzulli Institute of Radiology, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Close
,
Vojtech Pavlicek Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Close
,
Pascal Probst Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Pascal Probst in
Google Scholar
PubMed
Close
,
Fabian Hauswirth Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Close
,
Markus K Muller Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Markus K Muller in
Google Scholar
PubMed
Close
,
Magdalene Adamczyk Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Close
,
Achim Weber Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Achim Weber in
Google Scholar
PubMed
Close
,
Reto Martin Kaderli Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland

Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Close
, and
Pietro Renzulli Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
Close

. Such a cluster of endocrine diseases in a single person will eventually raise the suspicion of an underlying genetic mutation. A positive family history will further underline the need for genetic testing. The CDKN1B mutation as a causative factor

Open access
Hanna Karhapää Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Karhapää in
Google Scholar
PubMed
Close
,
Siru Mäkelä Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Siru Mäkelä in
Google Scholar
PubMed
Close
,
Hanna Laurén Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Laurén in
Google Scholar
PubMed
Close
,
Marjut Jaakkola Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Marjut Jaakkola in
Google Scholar
PubMed
Close
,
Camilla Schalin-Jäntti Medical Faculty, University of Helsinki, Helsinki, Finland
Endocrinology, Abdominal Centre, University of Helsinki and HUS, Helsinki, Finland

Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Close
, and
Micaela Hernberg Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Micaela Hernberg in
Google Scholar
PubMed
Close

. ICIs can generate autoimmune-like reactions towards one or multiple organs, including the gastrointestinal tract, skin, and endocrine glands ( 5 ). These AEs are classified as immune-related AEs (irAEs) and their seriousness varies from transient

Open access
Anna Gorbacheva Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Anna Gorbacheva in
Google Scholar
PubMed
Close
,
Anna Eremkina Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Anna Eremkina in
Google Scholar
PubMed
Close
,
Daria Goliusova Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Daria Goliusova in
Google Scholar
PubMed
Close
,
Julia Krupinova Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Julia Krupinova in
Google Scholar
PubMed
Close
, and
Natalia Mokrysheva Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Natalia Mokrysheva in
Google Scholar
PubMed
Close

intracellular signaling. Mutations in the menin gene cause the development of multiple endocrine neoplasia type 1 (MEN1) syndrome. This autosomal dominant disease is characterized by the formation of multiple tumors, predominantly located in the endocrine glands

Open access
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Close
,
Marilena Giannoudi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
Close
,
Satish S Kumar Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Satish S Kumar in
Google Scholar
PubMed
Close
,
Khyatisha Seejore Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed
Close
,
Georgios K Dimitriadis Department of Endocrinology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Close
,
Harpal Randeva Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Harpal Randeva in
Google Scholar
PubMed
Close
,
Adam Glaser Pediatric Oncology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute of Medical Research, University of Leeds, UK

Search for other papers by Adam Glaser in
Google Scholar
PubMed
Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Close
,
Georgina Gerrard Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Georgina Gerrard in
Google Scholar
PubMed
Close
,
Carmel Loughrey Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Carmel Loughrey in
Google Scholar
PubMed
Close
,
Ahmed Al-Qaissi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed
Close
,
Ramzi Ajjan Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed
Close
,
Julie Lynch Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Julie Lynch in
Google Scholar
PubMed
Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed
Close

the primary disease; however, an increase in cardiovascular mortality ( 3 ) and risk of early and late-occurring stroke ( 4 , 5 ) are also observed. There are limited cross-sectional studies evaluating conventional vascular risk factors in SCBT ( 6

Open access
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed
Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed
Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
Close

– death) and guide decisions regarding continuation of immunotherapy and need for an immunomodulatory intervention ( Table 1 ). Table 1 CTCAEv5 classification of endocrine dysfunction. CTCAE Toxicity Grade 1 2 3 4 5

Open access
Vita Birzniece School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Garvan Institute of Medical Research, New South Wales, Australia
School of Medical Sciences, University of New South Wales, New South Wales, Australia

Search for other papers by Vita Birzniece in
Google Scholar
PubMed
Close
,
Teresa Lam School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia
Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia

Search for other papers by Teresa Lam in
Google Scholar
PubMed
Close
,
Mark McLean School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Mark McLean in
Google Scholar
PubMed
Close
,
Navneeta Reddy Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Navneeta Reddy in
Google Scholar
PubMed
Close
,
Haleh Shahidipour School of Medicine, Western Sydney University, New South Wales, Australia
Department of Diabetes and Endocrinology, Blacktown Hospital, New South Wales, Australia

Search for other papers by Haleh Shahidipour in
Google Scholar
PubMed
Close
,
Amy Hayden School of Medicine, Western Sydney University, New South Wales, Australia
Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia
Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia

Search for other papers by Amy Hayden in
Google Scholar
PubMed
Close
,
Howard Gurney Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia

Search for other papers by Howard Gurney in
Google Scholar
PubMed
Close
,
Glenn Stone School of Computing, Engineering and Mathematics, Western Sydney University, New South Wales, Australia

Search for other papers by Glenn Stone in
Google Scholar
PubMed
Close
,
Rikke Hjortebjerg Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark

Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Close
, and
Jan Frystyk Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark

Search for other papers by Jan Frystyk in
Google Scholar
PubMed
Close

poorer cancer prognosis ( 1 , 2 ). Chronic hyperinsulinemia may stimulate carcinogenesis either directly through the insulin receptor or indirectly through insulin-like growth factor receptors (IGF-1Rs). Recent evidence indicates that the anti

Open access
Arnaud Lagarde Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France

Search for other papers by Arnaud Lagarde in
Google Scholar
PubMed
Close
,
Grégory Mougel Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France

Search for other papers by Grégory Mougel in
Google Scholar
PubMed
Close
,
Lucie Coppin Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 – CANTHER – Cancer – Heterogeneity Plasticity and Resistance to Therapies, Lille, France

Search for other papers by Lucie Coppin in
Google Scholar
PubMed
Close
,
Magalie Haissaguerre Service d’Endocrinologie, Centre Hospitalier Universitaire, Hôpital du Haut Levêque, Pessac, France

Search for other papers by Magalie Haissaguerre in
Google Scholar
PubMed
Close
,
Lauriane Le Collen Endocrinology, Diabetology and Nutrition Unit, University Hospital of Reims, Reims, France
Inserm/CNRS UMR 1283/8199, Pasteur Institute of Lille, EGID, Lille, France

Search for other papers by Lauriane Le Collen in
Google Scholar
PubMed
Close
,
Amira Mohamed Laboratory of Molecular Biology, Hospital La Conception, APHM, Marseille, France

Search for other papers by Amira Mohamed in
Google Scholar
PubMed
Close
,
Marc Klein Service Endocrinologie, CHU de Nancy, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France

Search for other papers by Marc Klein in
Google Scholar
PubMed
Close
,
Marie-Françoise Odou CHU Lille, Service de Biochimie et Biologie Moléculaire ‘Hormonologie, Métabolisme-Nutrition, Oncologie’, Lille, France
Univ. Lille, Inserm, CHU Lille, U1286 – Infinite – Institute for Translational Research in Inflammation, Lille, France

Search for other papers by Marie-Françoise Odou in
Google Scholar
PubMed
Close
,
Antoine Tabarin Service d’Endocrinologie, Centre Hospitalier Universitaire, Hôpital du Haut Levêque, Pessac, France

Search for other papers by Antoine Tabarin in
Google Scholar
PubMed
Close
,
Hedia Brixi Department of Gastroenterology and Digestive Oncology, Reims University Hospital, Reims, France

Search for other papers by Hedia Brixi in
Google Scholar
PubMed
Close
,
Thomas Cuny Aix Marseille Univ, APHM, INSERM, MMG, Department of Endocrinology, Hospital La Conception, Marseille, France

Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Close
,
Brigitte Delemer Endocrinology, Diabetology and Nutrition Unit, University Hospital of Reims, Reims, France

Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Close
,
Anne Barlier Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France

Search for other papers by Anne Barlier in
Google Scholar
PubMed
Close
, and
Pauline Romanet Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France

Search for other papers by Pauline Romanet in
Google Scholar
PubMed
Close

-Bauters C Costa A Ruszniewski P Niccoli P Ménégaux F Chabrier G Borson-Chazot F Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des tumeurs endocrines) cohort study among 758 patients . World Journal of Surgery 2010 34

Open access
Malgorzata Fuksiewicz Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed
Close
,
Maria Kowalska Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Maria Kowalska in
Google Scholar
PubMed
Close
,
Agnieszka Kolasinska-Cwikla Department of Oncology and Radiotherapy, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed
Close
, and
Beata Kotowicz Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Beata Kotowicz in
Google Scholar
PubMed
Close

prostate cancer may be associated with a component of neuroendocrine cells in adenocarcinoma or with the initiated process of transformation of cancer cells in the neuroendocrine direction. Elevated NSE levels are among the unfavourable prognostic factors

Open access
Jiaxin Luo Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Close
,
Weili Yin Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Weili Yin in
Google Scholar
PubMed
Close
,
Qiuxia Lin The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Qiuxia Lin in
Google Scholar
PubMed
Close
,
Juqing Wu Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Juqing Wu in
Google Scholar
PubMed
Close
,
Pan Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Pan Chen in
Google Scholar
PubMed
Close
,
Yuanna Ling Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Yuanna Ling in
Google Scholar
PubMed
Close
,
Jing Wang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Jing Wang in
Google Scholar
PubMed
Close
,
Zhen Li Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Zhen Li in
Google Scholar
PubMed
Close
,
Liqin Pan Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Liqin Pan in
Google Scholar
PubMed
Close
,
Yanying Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Yanying Chen in
Google Scholar
PubMed
Close
,
Wei Ouyang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Close
, and
Huijuan Feng Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Close

(LPFS) of bone foci. Given the negative impact of SREs on the quality of life, it is necessary to pay attention to the LPFS. In this study, the clinical characteristics of DTC bone metastases were described and analyzed so as to determine the factors

Open access